Hims & Hers Health Surges to 23rd Most Traded Stock with $2.48 Billion in Shares Exchanged

On June 16, 2025, Hims & Hers Health (HIMS) experienced a significant surge in trading volume, with a total of $2.48 billion in shares exchanged, marking a 68.22% increase from the previous day. This surge placed HIMS as the 23rd most traded stock of the day, reflecting heightened investor interest and activity.

Analysts have provided a mixed outlook for HIMS, with an average rating of "Hold" based on the assessments of 12 experts. The 12-month stock price forecast stands at $38.00, indicating a potential decrease of 36.01% from current levels. This cautious stance suggests that while there is potential for growth, investors should approach with prudence.

Earnings for Hims & Hers Health are projected to grow by 79.31% in the coming year, rising from $0.29 to $0.52 per share. This anticipated growth in earnings could be a driving factor behind the recent surge in trading volume and investor interest. The company's financial performance is expected to improve significantly, which may attract more buyers to the stock.

The stock's volatility has been notable over the past three months, with a weekly volatility of 16%. This level of volatility indicates that the stock price has been subject to significant fluctuations, which could present both opportunities and risks for traders. The recent trading day saw the stock fluctuate by 10.57% from its low to its high, highlighting the dynamic nature of the market for HIMS.

The news sentiment surrounding Hims & Hers Health, Inc. has been positive, with a 42.97% increase in positive news coverage. This positive sentiment could contribute to the stock's recent performance and may continue to influence investor perceptions and trading activity. The company's strong cash flow and low borrow rate of 1.19 days, along with a 34% short float, suggest that there is potential for a short squeeze, which could further drive the stock price higher.

Technical analysis indicates that HIMS is currently in a strong rising trend, with buy signals from both short and long-term moving averages. The stock is expected to rise by 93.83% over the next three months, with a 90% probability of holding a price between $92.37 and $148.06 at the end of this period. However, there are also some negative signals, including a sell signal from a pivot top point and the 3-month Moving Average Convergence Divergence (MACD), which could influence short-term price movements.